CAS 474960-44-6

2-Bromo-N-[4-chloro-3-[[(3R)-1-methyl-3-pyrrolidinyl]oxy]phenyl]-4,5-dimethoxybenzenesulfonamide

CAS: 474960-44-6

Formel: C₁₉H₂₂BrClN₂O₅S

Reinheit: 99%

Farbe und Form: Solid

Molekulargewicht: 505.8104

Ref: IN-DA00DGSZ

SB 657510

CAS: 474960-44-6

Formel: C₁₉H₂₂BrClN₂O₅S

Molekulargewicht: 505.81

Ref: 7W-GL4859

SB-657510

CAS: 474960-44-6

SB-657510

Formel: C₁₉H₂₂BrClN₂O₅S

Reinheit: ≥98%

Molekulargewicht: 505.81

Ref: 54-BUP08857

SB-657510

CAS: 474960-44-6

(R)-2-Bromo-N-(4-chloro-3-((1-methylpyrrolidin-3-yl)oxy)phenyl)-4,5-dimethoxybenzenesulfonamide

Formel: C₁₉H₂₂BrClN₂O₅S

Reinheit: 99%

Molekulargewicht: 505.81

Ref: IN-DG01178920

SB 657510

Kontrolliertes Produkt

CAS: 474960-44-6

Formel: C₁₉H₂₂BrClN₂O₅S

Farbe und Form: Neat

Molekulargewicht: 505.81

Ref: TR-S155043

SB 657510

CAS: 474960-44-6

SB 657510 is a pharmaceutical compound, classified as a small-molecule antiviral agent, which is derived through synthetic organic chemistry. It operates by targeting specific viral replication mechanisms, inhibiting the function of key viral enzymes necessary for the proliferation of viral particles. This mode of action disrupts the lifecycle of the virus and impairs its ability to spread within the host organism.

Formel: C₁₉H₂₂BrClN₂O₅S

Reinheit: Min. 95%

Molekulargewicht: 505.81 g/mol

Ref: 3D-ZTA96044

SB-657510

CAS: 474960-44-6

SB-657510: UT antagonist, Ki (nM) - human 61, monkey 17, cat 30, rat 65, mouse 56; reduces UII-induced inflammation, aids diabetic atherosclerosis.

Formel: C₁₉H₂₂BrClN₂O₅S

Reinheit: 98.06%

Farbe und Form: Solid

Molekulargewicht: 505.81

Ref: TM-T12848